{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:47:04Z","timestamp":1793677624856,"version":"4.5.1"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T00:00:00Z","timestamp":1380153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00109-013-1084-3","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T09:47:25Z","timestamp":1380102445000},"page":"107-115","source":"Crossref","is-referenced-by-count":121,"title":["Function of matrix IGF-1 in coupling bone resorption and formation"],"prefix":"10.1007","volume":"92","author":[{"given":"Janet L.","family":"Crane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,26]]},"reference":[{"key":"1084_CR1","first-page":"32","volume":"28","author":"D Agnusdei","year":"2005","unstructured":"Agnusdei D, Gentilella R (2005) GH and IGF-I as therapeutic agents for osteoporosis. J Endocrinol Investig 28:32\u201336","journal-title":"J Endocrinol Investig"},{"key":"1084_CR2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bone.2009.10.005","volume":"46","author":"R Rizzoli","year":"2010","unstructured":"Rizzoli R, Bianchi ML, Garabedian M, McKay HA, Moreno LA (2010) Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 46:294\u2013305","journal-title":"Bone"},{"key":"1084_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1745-7599.2004.tb00450.x","volume":"16","author":"AE Schettler","year":"2004","unstructured":"Schettler AE, Gustafson EM (2004) Osteoporosis prevention starts in adolescence. J Am Acad Nurse Pract 16:274\u2013282","journal-title":"J Am Acad Nurse Pract"},{"key":"1084_CR4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504\u20131508","journal-title":"Science"},{"key":"1084_CR5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13:791\u2013801","journal-title":"Nat Med"},{"key":"1084_CR6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","volume":"29","author":"S Khosla","year":"2008","unstructured":"Khosla S, Amin S, Orwoll E (2008) Osteoporosis in men. Endocr Rev 29:441\u2013464","journal-title":"Endocr Rev"},{"key":"1084_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11914-010-0035-y","volume":"8","author":"FA Syed","year":"2010","unstructured":"Syed FA, Ng AC (2010) The pathophysiology of the aging skeleton. Curr Osteoporos Reprod 8:235\u2013240","journal-title":"Curr Osteoporos Reprod"},{"key":"1084_CR8","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar J, Teitelbaum SL, Orchard PJ (2004) Osteopetrosis. N Engl J Med 351:2839\u20132849","journal-title":"N Engl J Med"},{"key":"1084_CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1196\/annals.1402.080","volume":"1116","author":"S Tung","year":"2007","unstructured":"Tung S, Iqbal J (2007) Evolution, aging, and osteoporosis. Ann N Y Acad Sci 1116:499\u2013506","journal-title":"Ann N Y Acad Sci"},{"key":"1084_CR10","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/8756-3282(95)00186-H","volume":"17","author":"JM Hayden","year":"1995","unstructured":"Hayden JM, Mohan S, Baylink DJ (1995) The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93S\u201398S","journal-title":"Bone"},{"key":"1084_CR11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-291X(89)92795-2","volume":"158","author":"RO Oreffo","year":"1989","unstructured":"Oreffo RO, Mundy GR, Seyedin SM, Bonewald LF (1989) Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem Biophys Res Commun 158:817\u2013823","journal-title":"Biochem Biophys Res Commun"},{"key":"1084_CR12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF02411301","volume":"34","author":"GR Mundy","year":"1982","unstructured":"Mundy GR, Rodan SB, Majeska RJ, DeMartino S, Trimmier C, Martin TJ, Rodan GA (1982) Unidirectional migration of osteosarcoma cells with osteoblast characteristics in response to products of bone resorption. Calcif Tissue Int 34:542\u2013546","journal-title":"Calcif Tissue Int"},{"key":"1084_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0221-8747(83)90005-X","volume":"5","author":"MJ Somerman","year":"1983","unstructured":"Somerman MJ, Hotchkiss RN, Bowers MR, Termine J (1983) Comparison of fetal and adult human bone: identification of a chemotactic factor in fetal bone. Metab Bone Dis Relat Res 5:75\u201379","journal-title":"Metab Bone Dis Relat Res"},{"issue":"Suppl 1","key":"1084_CR14","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/BF02406132","volume":"36","author":"AM Parfitt","year":"1984","unstructured":"Parfitt AM (1984) The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif Tissue Int 36(Suppl 1):S37\u2013S45","journal-title":"Calcif Tissue Int"},{"key":"1084_CR15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0889-8529(18)30348-7","volume":"18","author":"E Canalis","year":"1989","unstructured":"Canalis E, McCarthy TL, Centrella M (1989) The role of growth factors in skeletal remodeling. Endocrinol Metab Clin N Am 18:903\u2013918","journal-title":"Endocrinol Metab Clin N Am"},{"key":"1084_CR16","doi-asserted-by":"crossref","first-page":"21352","DOI":"10.1074\/jbc.M111663200","volume":"277","author":"SL Dallas","year":"2002","unstructured":"Dallas SL, Rosser JL, Mundy GR, Bonewald LF (2002) Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 277:21352\u201321360","journal-title":"J Biol Chem"},{"key":"1084_CR17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","volume":"15","author":"Y Tang","year":"2009","unstructured":"Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, Zhao L, Nagy TR, Peng X, Hu J et al (2009) TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15:757\u2013765","journal-title":"Nat Med"},{"key":"1084_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0304-4165(88)90127-4","volume":"966","author":"S Mohan","year":"1988","unstructured":"Mohan S, Jennings JC, Linkhart TA, Baylink DJ (1988) Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta 966:44\u201355","journal-title":"Biochim Biophys Acta"},{"key":"1084_CR19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","volume":"18","author":"L Xian","year":"2012","unstructured":"Xian L, Wu X, Pang L, Lou M, Rosen CJ, Qiu T, Crane J, Frassica F, Zhang L, Rodriguez JP et al (2012) Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 18:1095\u20131101","journal-title":"Nat Med"},{"key":"1084_CR20","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMe058080","volume":"352","author":"E Canalis","year":"2005","unstructured":"Canalis E (2005) The fate of circulating osteoblasts. N Engl J Med 352:2014\u20132016","journal-title":"N Engl J Med"},{"key":"1084_CR21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","volume":"126","author":"AJ Engler","year":"2006","unstructured":"Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126:677\u2013689","journal-title":"Cell"},{"key":"1084_CR22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1359\/jbmr.070306","volume":"22","author":"S Amin","year":"2007","unstructured":"Amin S, Riggs BL, Melton LJ III, Achenbach SJ, Atkinson EJ, Khosla S (2007) High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. J Bone Miner Res 22:799\u2013807","journal-title":"J Bone Miner Res"},{"key":"1084_CR23","first-page":"1009","volume":"78","author":"E Canalis","year":"1994","unstructured":"Canalis E (1994) Skeletal growth factors and aging. J Clin Endocrinol Metab 78:1009\u20131010","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s002230020048","volume":"70","author":"P Gillberg","year":"2002","unstructured":"Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG (2002) Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 70:22\u201329","journal-title":"Calcif Tissue Int"},{"key":"1084_CR25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535\u2013559","journal-title":"Endocr Rev"},{"key":"1084_CR26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.278.5337.419","volume":"278","author":"SW Lamberts","year":"1997","unstructured":"Lamberts SW, van den Beld AW, van der Lely AJ (1997) The endocrinology of aging. Science 278:419\u2013424","journal-title":"Science"},{"key":"1084_CR27","first-page":"4257","volume":"83","author":"JA Langlois","year":"1998","unstructured":"Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83:4257\u20134262","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00223-004-0187-9","volume":"75","author":"P Mezquita-Raya","year":"2004","unstructured":"Mezquita-Raya P, Munoz-Torres M, Alonso G, de Luna JD, Quesada JM, Dorado G, Luque-Recio F, Ruiz-Requena ME, Lopez-Rodriguez F, Escobar-Jimenez F (2004) Susceptibility for postmenopausal osteoporosis: interaction between genetic, hormonal and lifestyle factors. Calcif Tissue Int 75:373\u2013379","journal-title":"Calcif Tissue Int"},{"key":"1084_CR29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2005.06.016","volume":"37","author":"MB Patel","year":"2005","unstructured":"Patel MB, Arden NK, Masterson LM, Phillips DI, Swaminathan R, Syddall HE, Byrne CD, Wood PJ, Cooper C, Holt RI (2005) Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD). Bone 37:833\u2013841","journal-title":"Bone"},{"key":"1084_CR30","first-page":"392","volume":"22","author":"EJ Rhee","year":"2004","unstructured":"Rhee EJ, Oh KW, Lee WY, Kim SW, Oh ES, Baek KH, Kang MI, Park CY, Choi MG, Yoo HJ et al (2004) Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men. J Bone Miner Metab 22:392\u2013398","journal-title":"J Bone Miner Metab"},{"key":"1084_CR31","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1081447","volume":"299","author":"M Tatar","year":"2003","unstructured":"Tatar M, Bartke A, Antebi A (2003) The endocrine regulation of aging by insulin-like signals. Science 299:1346\u20131351","journal-title":"Science"},{"key":"1084_CR32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00223-005-0163-z","volume":"78","author":"T Yamaguchi","year":"2006","unstructured":"Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T (2006) Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int 78:18\u201324","journal-title":"Calcif Tissue Int"},{"key":"1084_CR33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.arr.2010.09.002","volume":"10","author":"E Ziv","year":"2011","unstructured":"Ziv E, Hu D (2011) Genetic variation in insulin\/IGF-1 signaling pathways and longevity. Ageing Res Rev 10:201\u2013204","journal-title":"Ageing Res Rev"},{"key":"1084_CR34","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1359\/jbmr.1999.14.12.2150","volume":"14","author":"S Boonen","year":"1999","unstructured":"Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ (1999) Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res 14:2150\u20132158","journal-title":"J Bone Miner Res"},{"key":"1084_CR35","first-page":"2799","volume":"82","author":"ES Kurland","year":"1997","unstructured":"Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799\u20132805","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR36","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jbmr.281","volume":"26","author":"C Ohlsson","year":"2011","unstructured":"Ohlsson C, Mellstrom D, Carlzon D, Orwoll E, Ljunggren O, Karlsson MK, Vandenput L (2011) Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J Bone Miner Res 26:865\u2013872","journal-title":"J Bone Miner Res"},{"key":"1084_CR37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0953-6205(02)00183-8","volume":"14","author":"PM Jehle","year":"2003","unstructured":"Jehle PM, Schulten K, Schulz W, Jehle DR, Stracke S, Manfras B, Boehm BO, Baylink DJ, Mohan S (2003) Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients. Eur J Intern Med 14:32\u201338","journal-title":"Eur J Intern Med"},{"key":"1084_CR38","first-page":"1011","volume":"78","author":"V Nicolas","year":"1994","unstructured":"Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR (1994) Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78:1011\u20131016","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR39","first-page":"2331","volume":"83","author":"T Seck","year":"1998","unstructured":"Seck T, Scheppach B, Scharla S, Diel I, Blum WF, Bismar H, Schmid G, Krempien B, Ziegler R, Pfeilschifter J (1998) Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab 83:2331\u20132337","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-006-9005-1","volume":"7","author":"M Misra","year":"2006","unstructured":"Misra M, Klibanski A (2006) Anorexia nervosa and osteoporosis. Rev Endocrinol Metab Disord 7:91\u201399","journal-title":"Rev Endocrinol Metab Disord"},{"key":"1084_CR41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/eje.1.01874","volume":"152","author":"T Ueland","year":"2005","unstructured":"Ueland T (2005) GH\/IGF-I and bone resorption in vivo and in vitro. Eur J Endocrinol 152:327\u2013332","journal-title":"Eur J Endocrinol"},{"key":"1084_CR42","first-page":"123","volume":"84","author":"T Ueland","year":"1999","unstructured":"Ueland T, Bollerslev J, Hansen TB, Ebbesen EN, Mosekilde L, Brixen K, Flyvbjerg A, Djoseland O (1999) Increased cortical bone content of insulin-like growth factors in acromegalic patients. J Clin Endocrinol Metab 84:123\u2013127","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","volume":"110","author":"S Yakar","year":"2002","unstructured":"Yakar S, Rosen CJ, Beamer WG, Ckert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR et al (2002) Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771\u2013781","journal-title":"J Clin Invest"},{"key":"1084_CR44","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jbmr.20","volume":"25","author":"S Elis","year":"2010","unstructured":"Elis S, Courtland HW, Wu Y, Rosen CJ, Sun H, Jepsen KJ, Majeska RJ, Yakar S (2010) Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1. J Bone Miner Res 25:1257\u20131266","journal-title":"J Bone Miner Res"},{"key":"1084_CR45","doi-asserted-by":"crossref","first-page":"19378","DOI":"10.1073\/pnas.0809223105","volume":"105","author":"E Stratikopoulos","year":"2008","unstructured":"Stratikopoulos E, Szabolcs M, Dragatsis I, Klinakis A, Efstratiadis A (2008) The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci U S A 105:19378\u201319383","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1084_CR46","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/en.2007-0608","volume":"148","author":"KE Govoni","year":"2007","unstructured":"Govoni KE, Wergedal JE, Florin L, Angel P, Baylink DJ, Mohan S (2007) Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Endocrinology 148:5706\u20135715","journal-title":"Endocrinology"},{"key":"1084_CR47","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1210\/endo.141.7.7585","volume":"141","author":"G Zhao","year":"2000","unstructured":"Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH et al (2000) Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674\u20132682","journal-title":"Endocrinology"},{"key":"1084_CR48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bone.2006.02.068","volume":"39","author":"J Jiang","year":"2006","unstructured":"Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE (2006) Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39:494\u2013504","journal-title":"Bone"},{"key":"1084_CR49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bone.2012.09.027","volume":"52","author":"MH Sheng","year":"2013","unstructured":"Sheng MH, Zhou XD, Bonewald LF, Baylink DJ, Lau KH (2013) Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice. Bone 52:133\u2013144","journal-title":"Bone"},{"key":"1084_CR50","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1359\/jbmr.060610","volume":"21","author":"Y Wang","year":"2006","unstructured":"Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD (2006) Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21:1350\u20131358","journal-title":"J Bone Miner Res"},{"key":"1084_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/endo.133.1.8319580","volume":"133","author":"E Canalis","year":"1993","unstructured":"Canalis E, Pash J, Gabbitas B, Rydziel S, Varghese S (1993) Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures. Endocrinology 133:33\u201338","journal-title":"Endocrinology"},{"key":"1084_CR52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1172\/JCI118121","volume":"96","author":"J Pfeilschifter","year":"1995","unstructured":"Pfeilschifter J, Laukhuf F, Muller-Beckmann B, Blum WF, Pfister T, Ziegler R (1995) Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96:767\u2013774","journal-title":"J Clin Invest"},{"key":"1084_CR53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0006-291X(88)80466-2","volume":"151","author":"CA Frolik","year":"1988","unstructured":"Frolik CA, Ellis LF, Williams DC (1988) Isolation and characterization of insulin-like growth factor-II from human bone. Biochem Biophys Res Commun 151:1011\u20131018","journal-title":"Biochem Biophys Res Commun"},{"key":"1084_CR54","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1210\/endo.142.6.8192","volume":"142","author":"N Miyakoshi","year":"2001","unstructured":"Miyakoshi N, Qin X, Kasukawa Y, Richman C, Srivastava AK, Baylink DJ, Mohan S (2001) Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 142:2641\u20132648","journal-title":"Endocrinology"},{"key":"1084_CR55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00298995","volume":"57","author":"CM Bagi","year":"1995","unstructured":"Bagi CM, DeLeon E, Brommage R, Rosen D, Sommer A (1995) Treatment of ovariectomized rats with the complex of rhIGF-I\/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck. Calcif Tissue Int 57:40\u201346","journal-title":"Calcif Tissue Int"},{"key":"1084_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/ghir.2000.0181","volume":"11","author":"F Bauss","year":"2001","unstructured":"Bauss F, Lang K, Dony C, Kling L (2001) The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration. Growth Hormon IGF Res 11:1\u20139","journal-title":"Growth Hormon IGF Res"},{"key":"1084_CR57","first-page":"801","volume":"18","author":"S Rajaram","year":"1997","unstructured":"Rajaram S, Baylink DJ, Mohan S (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18:801\u2013831","journal-title":"Endocr Rev"},{"key":"1084_CR58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1210\/jcem-67-3-509","volume":"67","author":"M Binoux","year":"1988","unstructured":"Binoux M, Hossenlopp P (1988) Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67:509\u2013514","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR59","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1210\/endo-127-6-3243","volume":"127","author":"RS Bar","year":"1990","unstructured":"Bar RS, Boes M, Dake BL, Sandra A, Bayne M, Cascieri M, Booth BA (1990) Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I. Endocrinology 127:3243\u20133245","journal-title":"Endocrinology"},{"key":"1084_CR60","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1210\/endo.140.12.7175","volume":"140","author":"N Miyakoshi","year":"1999","unstructured":"Miyakoshi N, Richman C, Qin X, Baylink DJ, Mohan S (1999) Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice. Endocrinology 140:5719\u20135728","journal-title":"Endocrinology"},{"key":"1084_CR61","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1359\/jbmr.2003.18.5.836","volume":"18","author":"M Zhang","year":"2003","unstructured":"Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL (2003) Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18:836\u2013843","journal-title":"J Bone Miner Res"},{"key":"1084_CR62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00467-004-1658-y","volume":"20","author":"KE Govoni","year":"2005","unstructured":"Govoni KE, Baylink DJ, Mohan S (2005) The multi-functional role of insulin-like growth factor binding proteins in bone. Pediatr Nephrol 20:261\u2013268","journal-title":"Pediatr Nephrol"},{"key":"1084_CR63","doi-asserted-by":"crossref","first-page":"20424","DOI":"10.1074\/jbc.270.35.20424","volume":"270","author":"S Mohan","year":"1995","unstructured":"Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ (1995) Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424\u201320431","journal-title":"J Biol Chem"},{"key":"1084_CR64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/endo.135.1.8013356","volume":"135","author":"RS Birnbaum","year":"1994","unstructured":"Birnbaum RS, Wiren KM (1994) Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology 135:223\u2013230","journal-title":"Endocrinology"},{"key":"1084_CR65","doi-asserted-by":"crossref","first-page":"29014","DOI":"10.1074\/jbc.M111.252585","volume":"286","author":"B Kim","year":"2011","unstructured":"Kim B, Huang G, Ho WB, Greenspan DS (2011) Bone morphogenetic protein-1 processes insulin-like growth factor-binding protein 3. J Biol Chem 286:29014\u201329025","journal-title":"J Biol Chem"},{"key":"1084_CR66","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1073\/pnas.96.6.3149","volume":"96","author":"JB Lawrence","year":"1999","unstructured":"Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR III, Conover CA (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 96:3149\u20133153","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1084_CR67","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1021\/bi026458q","volume":"41","author":"S Mohan","year":"2002","unstructured":"Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ (2002) ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 41:15394\u201315403","journal-title":"Biochemistry"},{"key":"1084_CR68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1096-6374(02)00046-1","volume":"12","author":"X Qin","year":"2002","unstructured":"Qin X, Sexton C, Byun D, Strong DD, Baylink DJ, Mohan S (2002) Differential regulation of pregnancy associated plasma protein (PAPP)-A during pregnancy in human and mouse. Growth Hormon IGF Res 12:359\u2013366","journal-title":"Growth Hormon IGF Res"},{"key":"1084_CR69","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1210\/endo.136.8.7543045","volume":"136","author":"KM Thrailkill","year":"1995","unstructured":"Thrailkill KM, Quarles LD, Nagase H, Suzuki K, Serra DM, Fowlkes JL (1995) Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527\u20133533","journal-title":"Endocrinology"},{"key":"1084_CR70","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbrc.2007.03.049","volume":"356","author":"Y Li","year":"2007","unstructured":"Li Y, Yu X, Lin S, Li X, Zhang S, Song YH (2007) Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 356:780\u2013784","journal-title":"Biochem Biophys Res Commun"},{"key":"1084_CR71","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1092053","volume":"302","author":"AJ Ridley","year":"2003","unstructured":"Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003) Cell migration: integrating signals from front to back. Science 302:1704\u20131709","journal-title":"Science"},{"key":"1084_CR72","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4248\/BR201302007","volume":"2","author":"JL Crane","year":"2013","unstructured":"Crane JL, Zhao L, Frye JS, Xian L, Qiu T, Cao X (2013) IGF-1 signaling is essential for differentiation of mesenchymal stem cells for peak bone mass. Bone Res 2:186\u2013194","journal-title":"Bone Res"},{"key":"1084_CR73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.200401138","volume":"166","author":"T Fujita","year":"2004","unstructured":"Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T (2004) Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166:85\u201395","journal-title":"J Cell Biol"},{"key":"1084_CR74","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","volume":"17","author":"T Negishi-Koga","year":"2011","unstructured":"Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, Friedel RH, Takayanagi H (2011) Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med 17:1473\u20131480","journal-title":"Nat Med"},{"key":"1084_CR75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/8756-3282(95)00485-8","volume":"18","author":"G Fiorelli","year":"1996","unstructured":"Fiorelli G, Formigli L, Zecchi OS, Gori F, Falchetti A, Morelli A, Tanini A, Benvenuti S, Brandi ML (1996) Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone 18:269\u2013276","journal-title":"Bone"},{"key":"1084_CR76","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1359\/jbmr.2001.16.12.2320","volume":"16","author":"D Bikle","year":"2001","unstructured":"Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B (2001) The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16:2320\u20132329","journal-title":"J Bone Miner Res"},{"key":"1084_CR77","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/endo.136.1.7828521","volume":"136","author":"PA Hill","year":"1995","unstructured":"Hill PA, Reynolds JJ, Meikle MC (1995) Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 136:124\u2013131","journal-title":"Endocrinology"},{"key":"1084_CR78","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s002239900141","volume":"59","author":"KB Jonsson","year":"1996","unstructured":"Jonsson KB, Wiberg K, Ljunghall S, Ljunggren O (1996) Insulin-like growth factor I does not stimulate bone resorption in cultured neonatal mouse calvarial bones. Calcif Tissue Int 59:366\u2013370","journal-title":"Calcif Tissue Int"},{"key":"1084_CR79","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1210\/endo.131.3.1505451","volume":"131","author":"H Mochizuki","year":"1992","unstructured":"Mochizuki H, Hakeda Y, Wakatsuki N, Usui N, Akashi S, Sato T, Tanaka K, Kumegawa M (1992) Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131:1075\u20131080","journal-title":"Endocrinology"},{"key":"1084_CR80","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1677\/joe.0.1320433","volume":"132","author":"MC Slootweg","year":"1992","unstructured":"Slootweg MC, Most WW, Van BE, Schot LP, Papapoulos SE, Lowik CW (1992) Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. J Endocrinol 132:433\u2013438","journal-title":"J Endocrinol"},{"key":"1084_CR81","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2002-020656","volume":"87","author":"J Rubin","year":"2002","unstructured":"Rubin J, Ckert-Bicknell CL, Zhu L, Fan X, Murphy TC, Nanes MS, Marcus R, Holloway L, Beamer WG, Rosen CJ (2002) IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. J Clin Endocrinol Metab 87:4273\u20134279","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR82","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI9017","volume":"105","author":"N Ogata","year":"2000","unstructured":"Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H (2000) Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105:935\u2013943","journal-title":"J Clin Invest"},{"key":"1084_CR83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1083\/jcb.200204046","volume":"159","author":"T Akune","year":"2002","unstructured":"Akune T, Ogata N, Hoshi K, Kubota N, Terauchi Y, Tobe K, Takagi H, Azuma Y, Kadowaki T, Nakamura K et al (2002) Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 159:147\u2013156","journal-title":"J Cell Biol"},{"key":"1084_CR84","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ncb2022","volume":"12","author":"T Qiu","year":"2010","unstructured":"Qiu T, Wu X, Zhang F, Clemens TL, Wan M, Cao X (2010) TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Nat Cell Biol 12:224\u2013234","journal-title":"Nat Cell Biol"},{"key":"1084_CR85","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1101\/gad.1702708","volume":"22","author":"M Wan","year":"2008","unstructured":"Wan M, Yang C, Li J, Wu X, Yuan H, Ma H, He X, Nie S, Chang C, Cao X (2008) Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev 22:2968\u20132979","journal-title":"Genes Dev"},{"key":"1084_CR86","first-page":"ra15","volume":"4","author":"M Wan","year":"2011","unstructured":"Wan M, Li J, Herbst K, Zhang J, Yu B, Wu X, Qiu T, Lei W, Lindvall C, Williams BO et al (2011) LRP6 mediates cAMP generation by G protein-coupled receptors through regulating the membrane targeting of Galpha(s). Sci Signal 4:ra15","journal-title":"Sci Signal"},{"key":"1084_CR87","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.1663","volume":"27","author":"B Yu","year":"2012","unstructured":"Yu B, Zhao X, Yang C, Crane J, Xian L, Lu W, Wan M, Cao X (2012) Parathyroid hormone induces differentiation of mesenchymal stromal\/stem cells by enhancing bone morphogenetic protein signaling. J Bone Miner Res 27:2001\u20132014","journal-title":"J Bone Miner Res"},{"key":"1084_CR88","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1210\/endo.142.10.8436","volume":"142","author":"N Miyakoshi","year":"2001","unstructured":"Miyakoshi N, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S (2001) Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 142:4349\u20134356","journal-title":"Endocrinology"},{"key":"1084_CR89","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1359\/jbmr.070517","volume":"22","author":"Y Wang","year":"2007","unstructured":"Wang Y, Nishida S, Boudignon BM, Burghardt A, Elalieh HZ, Hamilton MM, Majumdar S, Halloran BP, Clemens TL, Bikle DD (2007) IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res 22:1329\u20131337","journal-title":"J Bone Miner Res"},{"key":"1084_CR90","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1210\/en.2004-1511","volume":"146","author":"M Yamaguchi","year":"2005","unstructured":"Yamaguchi M, Ogata N, Shinoda Y, Akune T, Kamekura S, Terauchi Y, Kadowaki T, Hoshi K, Chung UI, Nakamura K et al (2005) Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. Endocrinology 146:2620\u20132628","journal-title":"Endocrinology"},{"key":"1084_CR91","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","volume":"17","author":"DD Bikle","year":"2002","unstructured":"Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP (2002) Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17:1570\u20131578","journal-title":"J Bone Miner Res"},{"key":"1084_CR92","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI113885","volume":"83","author":"E Canalis","year":"1989","unstructured":"Canalis E, Centrella M, Burch W, McCarthy TL (1989) Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60\u201365","journal-title":"J Clin Invest"},{"key":"1084_CR93","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jbmr.100","volume":"25","author":"S Elis","year":"2010","unstructured":"Elis S, Courtland HW, Wu Y, Fritton JC, Sun H, Rosen CJ, Yakar S (2010) Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact. J Bone Miner Res 25:2051\u20132058","journal-title":"J Bone Miner Res"},{"key":"1084_CR94","first-page":"22","volume":"33","author":"G Lombardi","year":"2010","unstructured":"Lombardi G, Di SC, Vuolo L, Guerra E, Scarano E, Colao A (2010) Role of IGF-I on PTH effects on bone. J Endocrinol Invest 33:22\u201326","journal-title":"J Endocrinol Invest"},{"key":"1084_CR95","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/8756-3282(94)00051-4","volume":"16","author":"P Watson","year":"1995","unstructured":"Watson P, Lazowski D, Han V, Fraher L, Steer B, Hodsman A (1995) Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16:357\u2013365","journal-title":"Bone"},{"key":"1084_CR96","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/mend-5-8-1081","volume":"5","author":"M Ernst","year":"1991","unstructured":"Ernst M, Rodan GA (1991) Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 5:1081\u20131089","journal-title":"Mol Endocrinol"},{"key":"1084_CR97","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jbmr.5650070410","volume":"7","author":"KJ Ibbotson","year":"1992","unstructured":"Ibbotson KJ, Orcutt CM, D'Souza SM, Paddock CL, Arthur JA, Jankowsky ML, Boyce RW (1992) Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res 7:425\u2013432","journal-title":"J Bone Miner Res"},{"key":"1084_CR98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1189\/jlb.70.2.297","volume":"70","author":"MG Brocardo","year":"2001","unstructured":"Brocardo MG, Schillaci R, Galeano A, Radrizzani M, White V, Guerrico AG, Santa-Coloma TA, Roldan A (2001) Early effects of insulin-like growth factor-1 in activated human T lymphocytes. J Leukoc Biol 70:297\u2013305","journal-title":"J Leukoc Biol"},{"key":"1084_CR99","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1010::AID-IMMU1010>3.0.CO;2-C","volume":"30","author":"PT Walsh","year":"2000","unstructured":"Walsh PT, O'Connor R (2000) The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur J Immunol 30:1010\u20131018","journal-title":"Eur J Immunol"},{"key":"1084_CR100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF03343975","volume":"25","author":"A Colao","year":"2002","unstructured":"Colao A, Ferone D, Marzullo P, Panza N, Pivonello R, Orio F Jr, Grande G, Bevilacqua N, Lombardi G (2002) Lymphocyte subset pattern in acromegaly. J Endocrinol Investig 25:125\u2013128","journal-title":"J Endocrinol Investig"},{"key":"1084_CR101","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jcem.87.6.8549","volume":"87","author":"T Ueland","year":"2002","unstructured":"Ueland T, Bollerslev J, Flyvbjerg A, Hansen TB, Vahl N, Mosekilde L (2002) Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 87:2760\u20132763","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR102","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jcem.87.6.8574","volume":"87","author":"S Grinspoon","year":"2002","unstructured":"Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A (2002) Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87:2883\u20132891","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR103","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jcem.87.4.8426","volume":"87","author":"S Boonen","year":"2002","unstructured":"Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, Adams S, Broos P, Lenaerts J, Raus J et al (2002) Musculoskeletal effects of the recombinant human IGF-I\/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 87:1593\u20131599","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR104","first-page":"1384","volume":"77","author":"PR Ebeling","year":"1993","unstructured":"Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL (1993) Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384\u20131387","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR105","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI118137","volume":"96","author":"SK Grinspoon","year":"1995","unstructured":"Grinspoon SK, Baum HB, Peterson S, Klibanski A (1995) Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900\u2013906","journal-title":"J Clin Invest"},{"key":"1084_CR106","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/0140-6736(92)91889-G","volume":"339","author":"AG Johansson","year":"1992","unstructured":"Johansson AG, Lindh E, Ljunghall S (1992) Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 339:1619","journal-title":"Lancet"},{"key":"1084_CR107","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/jbmr.5650101203","volume":"10","author":"LJ Ghiron","year":"1995","unstructured":"Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R (1995) Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J Bone Miner Res 10:1844\u20131852","journal-title":"J Bone Miner Res"},{"key":"1084_CR108","first-page":"1496","volume":"86","author":"AL Friedlander","year":"2001","unstructured":"Friedlander AL, Butterfield GE, Moynihan S, Grillo J, Pollack M, Holloway L, Friedman L, Yesavage J, Matthias D, Lee S et al (2001) One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab 86:1496\u20131503","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR109","first-page":"2143","volume":"83","author":"YJ Janssen","year":"1998","unstructured":"Janssen YJ, Hamdy NA, Frolich M, Roelfsema F (1998) Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 83:2143\u20132148","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR110","first-page":"2865","volume":"81","author":"G Johannsson","year":"1996","unstructured":"Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson BA (1996) Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865\u20132873","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR111","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-125-11-199612010-00003","volume":"125","author":"HB Baum","year":"1996","unstructured":"Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A (1996) Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 125:883\u2013890","journal-title":"Ann Intern Med"},{"key":"1084_CR112","doi-asserted-by":"crossref","first-page":"708","DOI":"10.7326\/0003-4819-124-8-199604150-00002","volume":"124","author":"MA Papadakis","year":"1996","unstructured":"Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C (1996) Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 124:708\u2013716","journal-title":"Ann Intern Med"},{"key":"1084_CR113","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2265.1998.00465.x","volume":"48","author":"A Rahim","year":"1998","unstructured":"Rahim A, Holmes SJ, Adams JE, Shalet SM (1998) Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Clin Endocrinol (Oxf) 48:463\u2013469","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1084_CR114","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1210\/jc.2002-021541","volume":"88","author":"WM Drake","year":"2003","unstructured":"Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hubner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO, Monson JP (2003) The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. J Clin Endocrinol Metab 88:1658\u20131663","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S8756-3282(03)00088-7","volume":"32","author":"T Sakata","year":"2003","unstructured":"Sakata T, Halloran BP, Elalieh HZ, Munson SJ, Rudner L, Venton L, Ginzinger D, Rosen CJ, Bikle DD (2003) Skeletal unloading induces resistance to insulin-like growth factor I on bone formation. Bone 32:669\u2013680","journal-title":"Bone"},{"key":"1084_CR116","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1359\/JBMR.0301241","volume":"19","author":"T Sakata","year":"2004","unstructured":"Sakata T, Wang Y, Halloran BP, Elalieh HZ, Cao J, Bikle DD (2004) Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways. J Bone Miner Res 19:436\u2013446","journal-title":"J Bone Miner Res"},{"key":"1084_CR117","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","volume":"363","author":"AG Renehan","year":"2004","unstructured":"Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346\u20131353","journal-title":"Lancet"},{"key":"1084_CR118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","volume":"95","author":"J Bell","year":"2010","unstructured":"Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B (2010) Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 95:167\u2013177","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR119","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","volume":"97","author":"JC Carel","year":"2012","unstructured":"Carel JC, Ecosse E, Landier F, Meguellati-Hakkas D, Kaguelidou F, Rey G, Coste J (2012) Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab 97:416\u2013425","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR120","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1210\/jc.2011-2882","volume":"97","author":"L Savendahl","year":"2012","unstructured":"Savendahl L, Maes M, Bertsson-Wikland K, Borgstrom B, Carel JC, Henrard S, Speybroeck N, Thomas M, Zandwijken G, Hokken-Koelega A (2012) Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study. J Clin Endocrinol Metab 97:E213\u2013E217","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpeds.2010.02.028","volume":"157","author":"P Wilton","year":"2010","unstructured":"Wilton P, Mattsson AF, Darendeliler F (2010) Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database). J Pediatr 157:265\u2013270","journal-title":"J Pediatr"},{"key":"1084_CR122","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2011-0112","volume":"96","author":"S Mackenzie","year":"2011","unstructured":"Mackenzie S, Craven T, Gattamaneni HR, Swindell R, Shalet SM, Brabant G (2011) Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab 96:2756\u20132761","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR123","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","volume":"91","author":"B Ergun-Longmire","year":"2006","unstructured":"Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494\u20133498","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR124","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","volume":"87","author":"CA Sklar","year":"2002","unstructured":"Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL (2002) Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87:3136\u20133141","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR125","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.2499","volume":"17","author":"X Cao","year":"2011","unstructured":"Cao X (2011) Targeting osteoclast\u2013osteoblast communication. Nat Med 17:1344\u20131346","journal-title":"Nat Med"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-013-1084-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-013-1084-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-013-1084-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T20:46:49Z","timestamp":1688503609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-013-1084-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,26]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1007\/s00109-013-1084-3","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,26]]}}}